CommercialCoverageMedium impact
07.10.04c, Parenterally Administered Terbutaline Sulfate for the Prevention or Treatment of Pre-Term Labor
Independence Blue Cross·OB-GYN·Medical Policy
Effective date
Aug 8, 2025
We identified it
Jun 19, 2026
Summary
A commercial policy regarding parenterally administered terbutaline sulfate for pre-term labor prevention/treatment has been archived. The policy is no longer active for commercial plans, meaning this treatment may no longer be covered or have specific billing requirements.
Action Required
By August 8, 2025: Billing team should verify coverage status for terbutaline sulfate injections used for pre-term labor with commercial payers before submitting claims. Update billing procedures to check individual payer policies since the standardized commercial policy has been archived. Contact payers directly for current coverage criteria to avoid claim denials.